Robert Alina M, Brown Jeremiah R, Sidhu Mandeep S, Ramanath Vijay S, Devries James T, Jayne John E, Hettleman Bruce D, Friedman Bruce J, Niles Nathaniel W, Kaplan Aaron V, Malenka David J, Robb John F, Thompson Craig A
Dartmouth Medical School, Dartmouth Hitchcock Medical Center, Cardiology, Lebanon, NH, USA.
Cardiovasc Revasc Med. 2012 Jan-Feb;13(1):3-10. doi: 10.1016/j.carrev.2011.05.006. Epub 2011 Nov 16.
The purpose of the study was to compare creatinine clearance (CrCl), estimated glomerular filtration rate (eGFR) and serum creatinine (SCr) in predicting contrast-induced acute kidney injury (CI-AKI), dialysis and death following percutaneous coronary intervention (PCI).
Data were prospectively collected on 7759 consecutive patients within the Dartmouth Dynamic Registry undergoing PCI between January 1, 2000, and December 31, 2006. Renal function was measured at baseline and within 48 h after PCI using three methods: CrCl using the Cockcroft-Gault equation, eGFR using the abbreviated Modification of Diet in Renal Disease equation and SCr. We compared CrCl, eGFR and SCr in predicting CI-AKI, post-PCI dialysis-dependent renal failure and in-hospital mortality. Areas under the receiver operating characteristic curve (ROC) were calculated using logistic regression and tested for equality.
On univariable analysis, CrCl [ROC: 0.69; 95% confidence interval (CI): 0.67-0.72] predicted CI-AKI better than eGFR (ROC: 0.67; 95% CI: 0.64-0.70) (P=.013) and SCr (ROC: 0.64; 95% CI: 0.61-0.67) (P<.001). Creatinine clearance (ROC: 0.73; 95% CI: 0.69-0.77) and eGFR (ROC: 0.70; 95% CI: 0.65-0.74) outperformed SCr for predicting in-hospital mortality. On multivariable analysis, CrCl (ROC: 0.77; 95% CI: 0.75-0.80), SCr (ROC: 0.78; 95% CI: 0.76-0.80) and eGFR (ROC: 0.77; 95% CI: 0.75-0.80) predicted CI-AKI well. Creatinine clearance (ROC: 0.88; 95% CI: 0.85-0.90) and eGFR (ROC: 0.87; 95% CI: 0.85-0.90) were strong independent predictors of in-hospital mortality.
Creatinine clearance, eGFR and SCr predict CI-AKI equally well. Creatinine clearance and eGFR are strong independent predictors of in-hospital mortality.
本研究旨在比较肌酐清除率(CrCl)、估算肾小球滤过率(eGFR)和血清肌酐(SCr)在预测经皮冠状动脉介入治疗(PCI)后对比剂诱导的急性肾损伤(CI-AKI)、透析及死亡方面的作用。
前瞻性收集了达特茅斯动态注册中心2000年1月1日至2006年12月31日期间连续接受PCI的7759例患者的数据。在基线及PCI后48小时内,采用三种方法测量肾功能:使用Cockcroft-Gault方程计算CrCl,使用简化的肾脏病饮食改良方程计算eGFR,以及测量SCr。我们比较了CrCl、eGFR和SCr在预测CI-AKI、PCI后依赖透析的肾衰竭及住院死亡率方面的表现。使用逻辑回归计算受试者工作特征曲线(ROC)下面积,并进行平等性检验。
单变量分析中,CrCl(ROC:0.69;95%置信区间[CI]:0.67 - 至0.72)预测CI-AKI的能力优于eGFR(ROC:0.67;95% CI:0.64 - 0.70)(P = 0.013)和SCr(ROC:0.64;95% CI:0.61 - 0.67)(P < 0.001)。肌酐清除率(ROC:0.73;95% CI:0.69 - 0.77)和eGFR(ROC:0.70;95% CI:0.65 - 0.74)在预测住院死亡率方面优于SCr。多变量分析中,CrCl(ROC:0.77;95% CI:0.75 - 0.80)、SCr(ROC:0.78;95% CI:0.76 - 至0.80)和eGFR(ROC:0.77;95% CI:0.75 - 0.80)对CI-AKI的预测效果良好。肌酐清除率(ROC:0.88;95% CI:0.85 - 0.90)和eGFR(ROC:0.87;95% CI:0.85 - 0.90)是住院死亡率的强有力独立预测因素。
肌酐清除率、eGFR和SCr对CI-AKI的预测能力相当。肌酐清除率和eGFR是住院死亡率的强有力独立预测因素。